All News

The Exposome is Everything in Atopic Dermatitis: An Expert Perspective on AD Pathophysiology
March 21, 2025

Raj Chovatiya, MD, PhD, MSCI, discusses the complex and widely variable influences that affect the manifestations and burden of atopic dermatitis across populations.

Universal ED Syphilis Screening Outperforms Targeted Approaches, Study Shows
March 20, 2025

CROI 2025: Researchers reported that a universal syphilis screening program identified more cases than programs targeting specific patient populations.

AGA: AI-Assisted Colonoscopy Increases Adenoma Detection, But Long-Term Benefits Unclear
March 20, 2025

New AGA guidelines conclude that it is not clear whether computer-aided detection systems for colonoscopy should be recommended for routine widespread use.

Melanin Isn't Everything: Skin Physiology Does Not Conform to Socially Defined Variables, Explains Raj Chovatiya, MD, PhD, MSCI
March 20, 2025

AAD 2025: Chovatiya discusses whether melanin concentration plays a role in skin physiology and cautioned against typing with factors that are not true biologic constructs.

Dupilumab Found Beneficial in COPD with Type 2 Inflammation: Daily Dose
March 20, 2025

Your daily dose of the clinical news you may have missed.

Improved HPV Vaccination Coverage May Help Prevent Noncervical Cancers in People with HIV
March 19, 2025

CROI 2025: Increased HPV vaccine coverage could reduce HIV cases by thousands, according to a new study.

US Adult Vaccination Snapshots: Current Coverage, Trends, and Concerns
March 19, 2025

Get the latest immunization updates, data on racial disparities, and practical guidance for clinical practice, here.

Massive Trump Administration Cuts to Federal Grants Halt National Diabetes Prevention Program
March 19, 2025

The 30-year program has tracked and compiled data on diabetes prevention, treatment, and outcomes, providing a foundation and insights for international research.

ZUPREME-1 Phase 2b Trial of Petrelentide for Obesity Completes Enrollment
March 19, 2025

The amylin analog at 5 doses will be compared with placebo when added to a reduced calorie diet and increased physical activity regimen for 42 weeks, said Zealand Pharma.

Roflumilast Cream Shows Strong Tolerability in Patients with AD Failing Other Topicals: Daily Dose
March 19, 2025

Your daily dose of the clinical news you may have missed.